;PMID: 3515856
;source_file_2920.mrg
;Release 0.9 of PennBioIE
;Funded by NSF ITR EIA-0205448

;0)section:[e:0..53] = [t:0..53]
;1)sentence:[e:59..128] = [t:59..128]
;2)sentence:[e:129..166] = [t:129..166]
;3)section:[e:170..205] = [t:170..205]
;4)sentence:[e:209..279] = [t:209..279]
;5)sentence:[e:280..441] = [t:280..441]
;6)sentence:[e:443..608] = [t:443..608]
;7)sentence:[e:609..759] = [t:609..759]
;8)sentence:[e:761..826] = [t:761..826]
;9)sentence:[e:827..910] = [t:827..910]
;10)sentence:[e:912..1059] = [t:912..1059]
;11)sentence:[e:1060..1143] = [t:1060..1143]
;12)sentence:[e:1144..1286] = [t:1144..1286]
;13)sentence:[e:1287..1423] = [t:1287..1423]
;14)section:[e:1427..1471] = [t:1427..1471]

;section 0 Span:0..53
;Acta Radiol Diagn (Stockh).  1986 Jan-Feb;27(1):3-10.
(SEC
  (FRAG (NNP:[0..4] Acta) (NNP:[5..11] Radiol) (NNP:[12..17] Diagn)
        (-LRB-:[18..19] -LRB-) (NN:[19..25] Stockh) (-RRB-:[25..26] -RRB-)
        (.:[26..27] .) (CD:[29..33] 1986) (NNP:[34..38] Jan-)
        (CD:[38..44] Feb;27) (-LRB-:[44..45] -LRB-) (CD:[45..46] 1)
        (-RRB-:[46..47] -RRB-) (::[47..48] :) (CD:[48..50] 3-) (CD:[50..52] 10)
        (.:[52..53] .)))

;sentence 1 Span:59..128
;Suprarenal haematoma versus neuroblastoma complicated by haemorrhage.
;[59..79]:malignancy-type:"Suprarenal haematoma"
;[87..100]:malignancy-type:"neuroblastoma"
(SENT
  (NP-HLN
    (NP (JJ:[59..69] Suprarenal) (NN:[70..79] haematoma))
    (PP (IN:[80..86] versus)
      (NP
        (NP (NN:[87..100] neuroblastoma))
        (VP (VBN:[101..112] complicated)
          (NP (-NONE-:[112..112] *))
          (PP (IN:[113..115] by)
            (NP-LGS (NN:[116..127] haemorrhage))))))
    (.:[127..128] .)))

;sentence 2 Span:129..166
;A  diagnostic dilemma in the newborn.
;[158..165]:malignancy-developmental-state:"newborn"
(SENT
  (NP-HLN
    (NP (DT:[129..130] A) (JJ:[132..142] diagnostic) (NN:[143..150] dilemma))
    (PP (IN:[151..153] in)
      (NP (DT:[154..157] the) (NN:[158..165] newborn)))
    (.:[165..166] .)))

;section 3 Span:170..205
;Eklof O, Mortensson W, Sandstedt B.
(SEC
  (FRAG (NNP:[170..175] Eklof) (NNP:[176..177] O) (,:[177..178] ,)
        (NNP:[179..189] Mortensson) (NNP:[190..191] W) (,:[191..192] ,)
        (NNP:[193..202] Sandstedt) (NNP:[203..205] B.)))

;sentence 4 Span:209..279
;Concomitant neonatal suprarenal haemorrhage and neuroblastoma is rare.
;[221..229]:malignancy-developmental-state:"neonatal"
;[257..270]:malignancy-type:"neuroblastoma"
(SENT
  (S
    (NP-SBJ (JJ:[209..220] Concomitant) (JJ:[221..229] neonatal)
      (NML
        (NML (JJ:[230..240] suprarenal) (NN:[241..252] haemorrhage))
        (CC:[253..256] and)
        (NML (NN:[257..270] neuroblastoma))))
    (VP (VBZ:[271..273] is)
      (ADJP-PRD (JJ:[274..278] rare)))
    (.:[278..279] .)))

;sentence 5 Span:280..441
;The  clinical and radiologic manifestations recorded in 11 patients with this
;entity  are compared with the findings in 32 cases with simple adrenal
;haemorrhage.
(SENT
  (S
    (NP-SBJ-1
      (NP (DT:[280..283] The)
        (ADJP (JJ:[285..293] clinical) (CC:[294..297] and)
              (JJ:[298..308] radiologic))
        (NNS:[309..323] manifestations))
      (VP (VBN:[324..332] recorded)
        (NP (-NONE-:[332..332] *))
        (PP-LOC (IN:[333..335] in)
          (NP
            (NP (CD:[336..338] 11) (NNS:[339..347] patients))
            (PP (IN:[348..352] with)
              (NP (DT:[353..357] this) (NN:[358..364] entity)))))))
    (VP (VBP:[366..369] are)
      (VP (VBN:[370..378] compared)
        (NP-1 (-NONE-:[378..378] *))
        (PP-CLR (IN:[379..383] with)
          (NP
            (NP (DT:[384..387] the) (NNS:[388..396] findings))
            (PP (IN:[397..399] in)
              (NP
                (NP (CD:[400..402] 32) (NNS:[403..408] cases))
                (PP (IN:[409..413] with)
                  (NP (JJ:[414..420] simple) (JJ:[421..428] adrenal)
                      (NN:[429..440] haemorrhage)))))))))
    (.:[440..441] .)))

;sentence 6 Span:443..608
;Because of the many similarities in presentation the combined lesion must
;always  be considered when a neonate is found to have a retroperitoneal,
;extra-renal  mass.
;[546..553]:malignancy-developmental-state:"neonate"
;[573..607]:malignancy-clinical-stage:"retroperitoneal, extra-renal  mass"
(SENT
  (S
    (PP (IN:[443..450] Because)
      (PP (IN:[451..453] of)
        (NP
          (NP (DT:[454..457] the) (JJ:[458..462] many)
              (NNS:[463..475] similarities))
          (PP (IN:[476..478] in)
            (NP (NN:[479..491] presentation))))))
    (NP-SBJ-1 (DT:[492..495] the) (VBN:[496..504] combined)
              (NN:[505..511] lesion))
    (VP (MD:[512..516] must)
      (ADVP-TMP (RB:[517..523] always))
      (VP (VB:[525..527] be)
        (VP (VBN:[528..538] considered)
          (NP-1 (-NONE-:[538..538] *))
          (SBAR-ADV
            (WHADVP-3 (WRB:[539..543] when))
            (S
              (NP-SBJ-2 (DT:[544..545] a) (NN:[546..553] neonate))
              (VP (VBZ:[554..556] is)
                (VP (VBN:[557..562] found)
                  (S
                    (NP-SBJ-2 (-NONE-:[562..562] *))
                    (VP (TO:[563..565] to)
                      (VP (VB:[566..570] have)
                        (NP (DT:[571..572] a)
                           (JJ:[573..588] retroperitoneal) (,:[588..589] ,)
                          (ADJP (AFX:[590..595] extra) (HYPH:[595..596] -)
                                (JJ:[596..601] renal))
                          (NN:[603..607] mass)))))
                  (ADVP-TMP-3 (-NONE-:[607..607] *T*)))))))))
    (.:[607..608] .)))

;sentence 7 Span:609..759
;Our present approach to the investigation includes conventional chest and 
;abdominal radiography aimed to demonstrate possible paravertebral widening.
(SENT
  (S
    (NP-SBJ
      (NP (PRP$:[609..612] Our) (JJ:[613..620] present) (NN:[621..629] approach))
      (PP (TO:[630..632] to)
        (NP (DT:[633..636] the) (NN:[637..650] investigation))))
    (VP (VBZ:[651..659] includes)
      (NP
        (NP
          (NP
            (ADJP-1 (JJ:[660..672] conventional))
            (NN:[673..678] chest)
            (NML-2 (-NONE-:[678..678] *P*)))
          (CC:[679..682] and)
          (NP
            (ADJP-1 (-NONE-:[682..682] *P*))
            (JJ:[684..693] abdominal)
            (NML-2 (NN:[694..705] radiography))))
        (VP (VBN:[706..711] aimed)
          (NP (-NONE-:[711..711] *))
          (S-PRP
            (NP-SBJ (-NONE-:[711..711] *))
            (VP (TO:[712..714] to)
              (VP (VB:[715..726] demonstrate)
                (NP (JJ:[727..735] possible) (JJ:[736..749] paravertebral)
                    (NN:[750..758] widening))))))))
    (.:[758..759] .)))

;sentence 8 Span:761..826
;Serial ultrasonographies are easy to carry out and indispensable.
(SENT
  (S
    (NP-SBJ (JJ:[761..767] Serial) (NNS:[768..785] ultrasonographies))
    (VP (VBP:[786..789] are)
      (ADJP-PRD
        (ADJP (JJ:[790..794] easy)
          (SBAR
            (WHNP-1 (-NONE-:[794..794] 0))
            (S
              (NP-SBJ (-NONE-:[794..794] *))
              (VP (TO:[795..797] to)
                (VP (VB:[798..803] carry)
                  (NP-1 (-NONE-:[803..803] *T*))
                  (PRT (RP:[804..807] out)))))))
        (CC:[808..811] and)
        (ADJP (JJ:[812..825] indispensable))))
    (.:[825..826] .)))

;sentence 9 Span:827..910
;The low  specificity of urography makes us refrain from this modality as a
;routine.
(SENT
  (S
    (NP-SBJ
      (NP (DT:[827..830] The) (JJ:[831..834] low) (NN:[836..847] specificity))
      (PP (IN:[848..850] of)
        (NP (NN:[851..860] urography))))
    (VP (VBZ:[861..866] makes)
      (S
        (NP-SBJ (PRP:[867..869] us))
        (VP (VB:[870..877] refrain)
          (PP-CLR (IN:[878..882] from)
            (NP (DT:[883..887] this) (NN:[888..896] modality)))
          (PP (IN:[897..899] as)
            (NP (DT:[900..901] a) (NN:[902..909] routine))))))
    (.:[909..910] .)))

;sentence 10 Span:912..1059
;Scintigraphy, in infants and children considered useful in demonstrating
;extent  and spread of neuroblastoma, has hardly been employed in neonates.
;[929..936]:malignancy-developmental-state:"infants"
;[941..949]:malignancy-developmental-state:"children"
;[1007..1020]:malignancy-type:"neuroblastoma"
;[1050..1058]:malignancy-developmental-state:"neonates"
(SENT
  (S
    (NP-SBJ-1
      (NP (NN:[912..924] Scintigraphy) (,:[924..925] ,))
      (VP
        (PP (IN:[926..928] in)
          (NP (NNS:[929..936] infants) (CC:[937..940] and)
              (NNS:[941..949] children)))
        (VBN:[950..960] considered)
        (S
          (NP-SBJ (-NONE-:[960..960] *))
          (ADJP-PRD (JJ:[961..967] useful)
            (PP (IN:[968..970] in)
              (S-NOM
                (NP-SBJ (-NONE-:[970..970] *))
                (VP (VBG:[971..984] demonstrating)
                  (NP
                    (NP (NN:[985..991] extent) (CC:[993..996] and)
                        (NN:[997..1003] spread))
                    (PP (IN:[1004..1006] of)
                      (NP (NN:[1007..1020] neuroblastoma)))))))))))
    (,:[1020..1021] ,)
    (VP (VBZ:[1022..1025] has)
      (ADVP (RB:[1026..1032] hardly))
      (VP (VBN:[1033..1037] been)
        (VP (VBN:[1038..1046] employed)
          (NP-1 (-NONE-:[1046..1046] *))
          (PP (IN:[1047..1049] in)
            (NP (NNS:[1050..1058] neonates))))))
    (.:[1058..1059] .)))

;sentence 11 Span:1060..1143
;The true  value of the modality in this particular age group remains to be
;settled.
(SENT
  (S
    (NP-SBJ
      (NP (DT:[1060..1063] The) (JJ:[1064..1068] true) (NN:[1070..1075] value))
      (PP (IN:[1076..1078] of)
        (NP (DT:[1079..1082] the) (NN:[1083..1091] modality)))
      (PP (IN:[1092..1094] in)
        (NP (DT:[1095..1099] this) (JJ:[1100..1110] particular)
            (NN:[1111..1114] age) (NN:[1115..1120] group))))
    (VP (VBZ:[1121..1128] remains)
      (S
        (NP-SBJ-1 (-NONE-:[1128..1128] *))
        (VP (TO:[1129..1131] to)
          (VP (VB:[1132..1134] be)
            (VP (VBN:[1135..1142] settled)
              (NP-1 (-NONE-:[1142..1142] *)))))))
    (.:[1142..1143] .)))

;sentence 12 Span:1144..1286
;CT  scanning does not seem to provide essential information additional to
;that of  sonography and may therefore be excluded from the protocol.
(SENT
  (S
    (NP-SBJ-1 (NN:[1144..1146] CT) (NN:[1148..1156] scanning))
    (VP
      (VP (VBZ:[1157..1161] does) (RB:[1162..1165] not)
        (VP (VB:[1166..1170] seem)
          (S
            (NP-SBJ-1 (-NONE-:[1170..1170] *))
            (VP (TO:[1171..1173] to)
              (VP (VB:[1174..1181] provide)
                (NP
                  (NP (JJ:[1182..1191] essential) (NN:[1192..1203] information))
                  (ADJP (JJ:[1204..1214] additional)
                    (PP (TO:[1215..1217] to)
                      (NP
                        (NP (DT:[1218..1222] that))
                        (PP (IN:[1223..1225] of)
                          (NP (NN:[1227..1237] sonography))))))))))))
      (CC:[1238..1241] and)
      (VP (MD:[1242..1245] may)
        (ADVP (RB:[1246..1255] therefore))
        (VP (VB:[1256..1258] be)
          (VP (VBN:[1259..1267] excluded)
            (NP-1 (-NONE-:[1267..1267] *))
            (PP (IN:[1268..1272] from)
              (NP (DT:[1273..1276] the) (NN:[1277..1285] protocol)))))))
    (.:[1285..1286] .)))

;sentence 13 Span:1287..1423
;Determination of  urinary excretion of catecholamine metabolites is of
;crucial significance and a  compulsory part of the investigation.
(SENT
  (S
    (NP-SBJ
      (NP (NN:[1287..1300] Determination))
      (PP (IN:[1301..1303] of)
        (NP
          (NP (JJ:[1305..1312] urinary) (NN:[1313..1322] excretion))
          (PP (IN:[1323..1325] of)
            (NP (NN:[1326..1339] catecholamine) (NNS:[1340..1351] metabolites))))))
    (VP (VBZ:[1352..1354] is)
      (UCP-PRD
        (PP (IN:[1355..1357] of)
          (NP (JJ:[1358..1365] crucial) (NN:[1366..1378] significance)))
        (CC:[1379..1382] and)
        (NP
          (NP (DT:[1383..1384] a) (JJ:[1386..1396] compulsory)
              (NN:[1397..1401] part))
          (PP (IN:[1402..1404] of)
            (NP (DT:[1405..1408] the) (NN:[1409..1422] investigation))))))
    (.:[1422..1423] .)))

;section 14 Span:1427..1471
;PMID: 3515856 [PubMed - indexed for MEDLINE]
(SEC
  (FRAG (NNP:[1427..1431] PMID) (::[1431..1432] :) (CD:[1433..1440] 3515856)
        (NN:[1441..1442] -LSB-) (NNP:[1442..1448] PubMed) (::[1449..1450] -)
        (NN:[1451..1458] indexed) (IN:[1459..1462] for)
        (NNP:[1463..1471] MEDLINE-RSB-)))
